Loading organizations...
§ Private Profile · 7 City Rd L 14, Auckland, Auckland, 1010, New Zealand
Cloud cardiology imaging platform for cardiologists, analyzing ultrasound images to diagnose cardiovascular disease.
HeartLab is an Auckland, New Zealand-based healthcare software company that provides a cloud-based cardiology imaging platform, offering a modern alternative to legacy on-premise PACS systems for echocardiograms and cardiac imaging. Its SaaS platform analyzes ultrasound images to facilitate the diagnosis of cardiovascular disease, streamlines reporting workflows, and generates comprehensive patient reports, enabling secure remote access for cardiologists and cardiac clinicians. The company has secured less than $5 million in total funding across two venture capital rounds and operates with fewer than 25 employees. HeartLab's product is currently deployed across healthcare providers in Australia and New Zealand, with strategic plans for expansion into the US and broader North American markets. Key leadership includes CEO Will Hewitt, CTO Richard Viney, Director of Quality & Regulatory Reneta Money, and CRO Matt Toulson, guiding its operational and market development. HeartLab was founded in 2018 by Will Hewitt.
HeartLab has raised $2.0M across 1 funding round.
HeartLab has raised $2.0M in total across 1 funding round.
HeartLab has raised $2.0M in total across 1 funding round.
HeartLab's investors include Correlation Ventures, DST Global, Felicis Ventures, ff Venture Capital, Founders Fund, FTX Ventures, Paradigm, Balaji Srinivasan, Justin Mateen, Dylan Field, Icehouse Ventures, Outset Ventures.
HeartLab is a New Zealand-based healthtech startup founded in 2018 that provides a cloud-based cardiology imaging platform designed to replace legacy on-premise PACS (Picture Archiving and Communication Systems) products. It offers an end-to-end solution for echocardiograms—ultrasound tests used to examine heart structure and function—using AI to analyze images, streamline workflows, generate patient reports, and enable remote access from connected devices, serving cardiologists, clinicians, and healthcare teams diagnosing cardiovascular disease.[1][2][3][4]
The platform targets hospitals, clinics, and cardiology practices worldwide, solving key pain points like manual review of time-consuming scans, inefficient data sharing, and limited remote collaboration. HeartLab has raised under $5 million across two funding rounds (including $3.5 million from Founders Fund), grown its team to double digits, and expanded from New Zealand to clinics in Australia and the US, where heart disease is the leading cause of death, demonstrating strong early momentum amid rising demand for AI-driven cardiac care.[1][2]
HeartLab was co-founded in 2018 by Will Hewitt, who was just 18 years old at the time, alongside a team addressing the manual, time-intensive process of reviewing echocardiograms for heart disease diagnosis—one of the world's most preventable causes of death. Based in Auckland, New Zealand, Hewitt's vision emerged from recognizing how AI could accelerate insights from these scans, reducing clinician workload and improving accuracy.[2][4]
Early traction came through New Zealand's healthtech ecosystem, including Callaghan Innovation support for incubation, funding, interns, and market validation. Pivotal moments include raising $3.5 million from Founders Fund, team expansion, and international launches in Australia and the US after initial NZ testing, navigating challenges as a regulated medical device.[2]
HeartLab stands out in cardiology imaging through these key strengths:
HeartLab rides the AI-healthtech wave in cardiovascular care, where heart disease drives massive need—especially in the US—and cloud/AI tools address clinician shortages, rising imaging volumes, and post-pandemic remote work demands. Its timing aligns with global regulatory shifts enabling SaaS medical devices and exploding demand for efficient diagnostics amid aging populations and preventable disease burdens.[2][3]
Market forces like healthtech funding ecosystems (e.g., Callaghan Innovation, Founders Fund) and cross-border expansion favor HeartLab, positioning it to influence cardiology by standardizing cloud workflows, boosting AI adoption in imaging, and enabling faster interventions that could scale to reduce global heart disease mortality.[1][2]
HeartLab's youth belies its poised trajectory: expect accelerated US penetration as the largest heart disease market, potential Series A funding to fuel AI enhancements, and partnerships with major EHR systems for broader integration. Trends like multimodal AI (combining imaging with genomics) and telecardiology will amplify its edge, evolving it from niche echocardiogram tool to comprehensive cardiac platform.
With founder Will Hewitt's bold start at 18, HeartLab exemplifies how AI can humanize high-stakes healthcare, delivering the end-to-end efficiency that cardiologists need to fight the cardiovascular crisis head-on.[2][4]
HeartLab has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in September 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 1, 2021 | $2M Seed | — | Correlation Ventures, DST Global, Felicis Ventures, FF Venture Capital, Founders Fund, FTX Ventures, Paradigm, Balaji Srinivasan, Justin Mateen, Dylan Field, Icehouse Ventures, Outset Ventures | Announced |